Purification of Heart Cells from Stem Cells Using VCAM1
Author Information
Author(s): Uosaki Hideki, Fukushima Hiroyuki, Takeuchi Ayako, Matsuoka Satoshi, Nakatsuji Norio, Yamanaka Shinya, Yamashita Jun K.
Primary Institution: Kyoto University, Kyoto, Japan
Hypothesis
Can VCAM1 be used as a reliable marker for purifying cardiomyocytes from human embryonic and induced pluripotent stem cells?
Conclusion
The study successfully identified VCAM1 as a potent marker for efficiently purifying cardiomyocytes from human embryonic and induced pluripotent stem cells.
Supporting Evidence
- Cardiac troponin-T positive cardiomyocytes appeared with 30-70% efficiency using the differentiation method.
- VCAM1 was identified as a specific marker for cardiomyocytes, with 95-98% of VCAM1-positive cells also being TNNT2-positive.
- The purification method yielded 5-10×10^5 VCAM1-positive cells from a single well of a six-well culture plate.
Takeaway
Scientists found a way to easily separate heart cells from stem cells using a special marker called VCAM1, which helps make sure the heart cells are pure and ready for use.
Methodology
The study used a differentiation protocol for hESCs and hiPSCs, screening 242 antibodies to identify VCAM1 as a specific marker for cardiomyocytes.
Limitations
The study did not fully characterize the identity of VCAM1-positive/TNNT2-negative cells, which may include non-cardiomyocyte populations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website